Complete BCAB Stock Valuation Analysis
Comprehensive intrinsic value analysis using 1 different methodologies
BCAB Peer Valuation Analysis
Relative valuation based on comparable company trading multiples
Peer Valuation Analysis
Fair Value Range Analysis
Based on median multiples from 8 peer companies in Healthcare
P/E Ratio
$0.00
-100.0%
Peer Median: 0.0x
EV/EBITDA
$0.00
-100.0%
Peer Median: 0.0x
P/S Ratio
$0.39
+0.0%
Peer Median: 2.1x
Interpretation: Each multiple provides a different perspective on fair value. Consider which multiple is most relevant for BCAB's business model and current situation.
Multiple Comparison
| Multiple | BCAB Current | Peer Median | Peer Average | Premium/Discount | Assessment |
|---|---|---|---|---|---|
| P/E Ratio | -0.4x | 0.0x | 0.0x | -Infinity% | Undervalued |
| EV/EBITDA | -Infinityx | 0.0x | 0.0x | -Infinity% | Undervalued |
| P/S Ratio | 2.1x | 2.1x | 2.1x | 0.0% | Fair Value |
Peer Companies
Click any company to view their valuation
| Company | Market Cap | P/E Ratio | EV/EBITDA | P/S Ratio |
|---|---|---|---|---|
| $0.02B | 0.0x | 0.0x | 0.0x | |
| $0.03B | 0.0x | 0.0x | 98.8x | |
| $0.04B | 0.0x | 0.0x | 77.0x | |
| $0.03B | 0.0x | 0.0x | 57.8x | |
| $0.02B | 0.0x | 0.0x | 2.1x | |
| $0.02B | 0.0x | 0.0x | 0.0x | |
| $0.02B | 0.0x | 0.0x | 24.6x | |
| $0.03B | 206.2x | 143.3x | 0.0x |